Interestingly, the magnitude and frequency of CTA- and SALL4-specific T cell responses was decreased in patients with advanced-stage HCC compared to those with early-stage HCC, although not all differences reached statistical significance. Here, SALL4 is linked to hepatocellular carcinoma.